FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4366352793> ?p ?o ?g. }

• W4366352793 endingPage "e0284442" @default.
• W4366352793 startingPage "e0284442" @default.
• W4366352793 abstract "To evaluate and compare the efficacy and safety of intravenous (IV) glucocorticoid therapy with those of oral glucocorticoids as a first-line treatment for IgG4-related ophthalmic disease (IgG4-ROD).We retrospectively reviewed the medical records of patients who underwent systemic glucocorticoid therapy for biopsy-proven IgG4-ROD from June 2012 to June 2022. Glucocorticoids were given either oral prednisolone at an initial dose of 0.6 mg/kg/day for four weeks with subsequent tapering or once weekly IV methylprednisolone (500 mg for six weeks, then 250 mg for six weeks), according to the date of treatment. Clinicoserological features, initial response, relapse during follow-ups, cumulative doses of glucocorticoids, and adverse effects of glucocorticoids were compared for the IV and oral steroid groups.Sixty one eyes of 35 patients were evaluated over a median follow-up period of 32.9 months. The complete response rate was significantly higher in the IV steroid group (n = 30 eyes) than in the oral steroid group (n = 31 eyes) (66.7% vs. 38.7%, p = 0.041). Kaplan-Meier analysis showed that the 2-year relapse-free survival was 71.5% (95% confidence interval: 51.6-91.4) and 21.5% (95% confidence interval: 4.5-38.5) in the IV steroid and oral steroid group, respectively (p < 0.001). Although the cumulative dose of glucocorticoids was significantly higher in the IV steroid group than in the oral steroid group (7.8 g vs. 4.9 g, p = 0.012), systemic and ophthalmic adverse effects were not significantly different between the two groups throughout follow-ups (all p > 0.05).As a first-line treatment for IgG4-ROD, IV glucocorticoid therapy was well-tolerated, led to better clinical remission and more effectively prevented inflammatory relapse than oral steroids. Further research is needed to establish guidelines on dosage regimens." @default.
• W4366352793 created "2023-04-21" @default.
• W4366352793 creator A5004529998 @default.
• W4366352793 creator A5033291636 @default.
• W4366352793 creator A5042225318 @default.
• W4366352793 creator A5057549647 @default.
• W4366352793 date "2023-04-19" @default.
• W4366352793 modified "2023-09-30" @default.
• W4366352793 title "Efficacy and safety of intravenous glucocorticoid therapy for IgG4-related ophthalmic disease" @default.
• W4366352793 cites W1598169396 @default.
• W4366352793 cites W1951548607 @default.
• W4366352793 cites W1974104888 @default.
• W4366352793 cites W1979173488 @default.
• W4366352793 cites W1992168643 @default.
• W4366352793 cites W2005545700 @default.
• W4366352793 cites W2010033528 @default.
• W4366352793 cites W2021988356 @default.
• W4366352793 cites W2047214267 @default.
• W4366352793 cites W2052463348 @default.
• W4366352793 cites W2066663435 @default.
• W4366352793 cites W2082783569 @default.
• W4366352793 cites W2108302885 @default.
• W4366352793 cites W2113684011 @default.
• W4366352793 cites W2113806600 @default.
• W4366352793 cites W2125813424 @default.
• W4366352793 cites W2138593008 @default.
• W4366352793 cites W2141351444 @default.
• W4366352793 cites W2158821675 @default.
• W4366352793 cites W2195899197 @default.
• W4366352793 cites W2288910126 @default.
• W4366352793 cites W2430629879 @default.
• W4366352793 cites W2551766077 @default.
• W4366352793 cites W2758287922 @default.
• W4366352793 cites W2766342670 @default.
• W4366352793 cites W2787136837 @default.
• W4366352793 cites W2804042704 @default.
• W4366352793 cites W2895910834 @default.
• W4366352793 cites W2900450656 @default.
• W4366352793 cites W2911475862 @default.
• W4366352793 cites W2941838460 @default.
• W4366352793 cites W2955638605 @default.
• W4366352793 cites W3012149677 @default.
• W4366352793 cites W3023529892 @default.
• W4366352793 cites W3140754719 @default.
• W4366352793 cites W3193239659 @default.
• W4366352793 cites W4200213972 @default.
• W4366352793 cites W4207002861 @default.
• W4366352793 cites W4214653586 @default.
• W4366352793 cites W2399746749 @default.
• W4366352793 doi "https://doi.org/10.1371/journal.pone.0284442" @default.
• W4366352793 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37075036" @default.
• W4366352793 hasPublicationYear "2023" @default.
• W4366352793 type Work @default.
• W4366352793 citedByCount "0" @default.
• W4366352793 crossrefType "journal-article" @default.
• W4366352793 hasAuthorship W4366352793A5004529998 @default.
• W4366352793 hasAuthorship W4366352793A5033291636 @default.
• W4366352793 hasAuthorship W4366352793A5042225318 @default.
• W4366352793 hasAuthorship W4366352793A5057549647 @default.
• W4366352793 hasBestOaLocation W43663527931 @default.
• W4366352793 hasConcept C126322002 @default.
• W4366352793 hasConcept C141071460 @default.
• W4366352793 hasConcept C167135981 @default.
• W4366352793 hasConcept C197934379 @default.
• W4366352793 hasConcept C2776715498 @default.
• W4366352793 hasConcept C2776804153 @default.
• W4366352793 hasConcept C2780372218 @default.
• W4366352793 hasConcept C2780841215 @default.
• W4366352793 hasConcept C44249647 @default.
• W4366352793 hasConcept C71924100 @default.
• W4366352793 hasConcept C90924648 @default.
• W4366352793 hasConceptScore W4366352793C126322002 @default.
• W4366352793 hasConceptScore W4366352793C141071460 @default.
• W4366352793 hasConceptScore W4366352793C167135981 @default.
• W4366352793 hasConceptScore W4366352793C197934379 @default.
• W4366352793 hasConceptScore W4366352793C2776715498 @default.
• W4366352793 hasConceptScore W4366352793C2776804153 @default.
• W4366352793 hasConceptScore W4366352793C2780372218 @default.
• W4366352793 hasConceptScore W4366352793C2780841215 @default.
• W4366352793 hasConceptScore W4366352793C44249647 @default.
• W4366352793 hasConceptScore W4366352793C71924100 @default.
• W4366352793 hasConceptScore W4366352793C90924648 @default.
• W4366352793 hasIssue "4" @default.
• W4366352793 hasLocation W43663527931 @default.
• W4366352793 hasLocation W43663527932 @default.
• W4366352793 hasLocation W43663527933 @default.
• W4366352793 hasOpenAccess W4366352793 @default.
• W4366352793 hasPrimaryLocation W43663527931 @default.
• W4366352793 hasRelatedWork W1575218092 @default.
• W4366352793 hasRelatedWork W1974164973 @default.
• W4366352793 hasRelatedWork W1990686131 @default.
• W4366352793 hasRelatedWork W2049462622 @default.
• W4366352793 hasRelatedWork W2055857629 @default.
• W4366352793 hasRelatedWork W2072798947 @default.
• W4366352793 hasRelatedWork W2084780183 @default.
• W4366352793 hasRelatedWork W2319040444 @default.
• W4366352793 hasRelatedWork W2418552380 @default.
• W4366352793 hasRelatedWork W3030675548 @default.

• next